Drug Type Induced pluripotent stem cells (iPSC), Neural stem cell therapy |
Synonyms Human motor neural progenitor cell |
Target- |
Action- |
Mechanism Cell replacements |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | China | 25 Jul 2022 | |
Spinal Cord Injuries | Preclinical | China | 25 Jul 2022 | |
Amyotrophic Lateral Sclerosis 11 | Discovery | China | 30 Jan 2022 |